PUBLIC CONTRACT · 2023
41/9039/2023 - Convite ao abrigo do(s) acordo(s)-quadro 2020/9 - Derivados do plasma humano e 2021/55 - Medicamentos diversos para suprir necessidades na área da saúde
- Contract value
- €163,884.00
- Signed on
- 4 May 2023
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11591124PUBLISHED DESCRIPTION
460/2023
Parties involved
- Place of performance
- Portugal, Faro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- grifols · Tax ID 502041285
- Awardee
- cls · Tax ID 503047201
- Bidder
- Octapharma - Produtos Farmacêuticos, Lda. · Tax ID 502820780
- Bidder
- KEDRION BIOPHARMA · Tax ID 980701996
Values and timeline
- Contract price
- €163,884.00
- Procedure base price
- €5,275,988.58
- Total effective price
- Not reported on Portal BASE
- Publication date
- 18 July 2025
- Award date
- 4 May 2023
- Signing date
- 4 May 2023
- Performance period
- 274 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2020/9 - Derivados do plasma humano
- Centralised procedure
- Yes
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6532260
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.